| To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery (NCT05308771) | Centre Hospitalier Universitaire de Tivoli | 2022-03-25 |
| Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma (NCT05135832) | Herlev and Gentofte Hospital | 2021-12-13 |
| Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney Specimen (NCT05135520) | Seoul National University Bundang Hospital | 2021-11-29 |
| Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000). (NCT05025930) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-10-01 |
| Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) (NCT04922047) | RenJi Hospital | 2021-06-01 |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations (NCT04579380) | Seagen, a wholly owned subsidiary of Pfizer | 2021-01-11 |
| Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery (NCT04630483) | Medipol University | 2020-11-23 |
| Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy (NCT04442724) | Cedars-Sinai Medical Center | 2020-07-01 |
| Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04644432) | Herlev and Gentofte Hospital | 2020-03-06 |
| Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer (NCT04052113) | AstraZeneca | 2019-10-25 |
| LPN in Patients With High-complex Renal Tumors (NCT04933604) | Samsun Liv Hospital | 2019-09-01 |
| Evaluation of NanoDoce® in Participants With Urothelial Carcinoma (NCT03636256) | NanOlogy, LLC | 2019-04-02 |
| Laparoscopic Partial Nephrectomy for cT1 Tumors (NCT04213157) | Samsun Liv Hospital | 2019-03-15 |
| Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study (NCT04702347) | Fundacio Puigvert | 2019-02-01 |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| Pre-Operative Single Shot Rectus Sheath Block (NCT03458598) | University of Alberta | 2018-02-16 |
| Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy (NCT03595813) | Institut Paoli-Calmettes | 2018-01-29 |
| A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer (NCT03288545) | Astellas Pharma Global Development, Inc. | 2017-10-11 |
| A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT03219333) | Astellas Pharma Inc | 2017-10-08 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
| A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery (NCT03010813) | Chinese University of Hong Kong | 2016-12-01 |
| Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy (NCT02780687) | Boehringer Ingelheim | 2016-06-09 |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer (NCT02543645) | Celldex Therapeutics | 2015-10-01 |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma (NCT02386111) | Celldex Therapeutics | 2015-05-01 |
| Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Specimen (NCT05113134) | Seoul National University Bundang Hospital | 2015-03-02 |
| Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients (NCT02891460) | UroGen Pharma Ltd. | 2013-01-01 |
| Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy (NCT04649970) | Université de Sousse | 2013-01-01 |
| A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer (NCT01454089) | Achieve Life Sciences | 2011-10-01 |
| Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer (NCT01155791) | Sandy Srinivas | 2010-04-01 |
| Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable) (NCT00374868) | Eli Lilly and Company | 2006-08-01 |
| 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen (NCT00191971) | Eli Lilly and Company | 2004-01-01 |
| Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer (NCT00226954) | Stanford University | 2003-03-01 |
| Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium (NCT00034177) | Achieve Life Sciences | 2002-04-01 |
| Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer (NCT00384891) | Medical Enterprises Europe B.V. | 2002-02-01 |
| Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer (NCT00151034) | University of Michigan Rogel Cancer Center | 2000-09-01 |
| Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples (NCT00001814) | National Cancer Institute (NCI) | 1999-04-01 |
| Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer (NCT00134186) | Pharmacyclics LLC. | |
| A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium (NCT00034593) | Eli Lilly and Company | |
| SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (NCT02254915) | Medical Enterprises Europe B.V. | |
| A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium (NCT00035061) | Eli Lilly and Company | |